Skip to Main Content

Paper Details

Exome Sequencing in Children With Pulmonary Arterial Hypertension Demonstrates Differences Compared With Adults.
Circ Genom Precis Med
78
2018
BMPR2, BMPR2 mutations, Children, FPAH, IPAH, PAH, PAH risk genes, Pulmonary Arterial Hypertension, Pulmonary arterial hypertension, TBX4, TBX4 mutations, children, familial PAH, heart failure, idiopathic, novel genes, patients, risk genes
Author NameAffiliation
Dunbar IvyHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Eric D AustinHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Rizwan HamidHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Rizwan HamidHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Ashley SawleHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Jeffrey G ReidHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Jeffrey G ReidHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
John D OvertonHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
John D OvertonHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Aris BarasHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Frederick E DeweyHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Yufeng ShenHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Wendy K ChungHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
Wendy K ChungHerbert Irving Comprehensive Cancer Center (A.S., Columbia University Medical Center, Columbia University, Regeneron Pharmaceuticals, Children's Hospital Colorado, Vanderbilt University School of Medicine, Cincinnati Children's Hospital Medical Center and Department of Pediatrics, University of Cincinnati College of Medicine
  • 1 - 14

Datasets